Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-022122
Filing Date
2011-03-04
Accepted
2011-03-04 14:49:56
Documents
14
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a58867e10vk.htm 10-K 670383
2 EX-10.19 a58867exv10w19.htm EX-10.19 49639
3 EX-10.20 a58867exv10w20.htm EX-10.20 49839
4 EX-10.21 a58867exv10w21.htm EX-10.21 49430
5 EX-10.22 a58867exv10w22.htm EX-10.22 43391
6 EX-10.23 a58867exv10w23.htm EX-10.23 240233
7 EX-23.1 a58867exv23w1.htm EX-23.1 2133
8 EX-31.1 a58867exv31w1.htm EX-31.1 8113
9 EX-31.2 a58867exv31w2.htm EX-31.2 8400
10 EX-32.1 a58867exv32w1.htm EX-32.1 3426
11 GRAPHIC a58867a5886700.gif GRAPHIC 13823
12 GRAPHIC a58867a5886701.gif GRAPHIC 88535
13 GRAPHIC a58867a5886702.gif GRAPHIC 7190
14 GRAPHIC a58867a5886703.gif GRAPHIC 90560
  Complete submission text file 0000950123-11-022122.txt   1402266
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50632 | Film No.: 11664215
SIC: 2834 Pharmaceutical Preparations